Pionyr Immunotherapeutics Investors

33 investors on Angel Roster list Pionyr Immunotherapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Canada and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Pionyr Immunotherapeutics can appear together.

Investors listed
33
With verified email
58%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 33 Pionyr Immunotherapeutics investors

The most complete profiles first. Showing 33 of 33.

  • Eugene HillVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Verified email available

  • Jack KenneyVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Louis BernemanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Manny StockmanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Paul LaVioletteVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Verified email available

  • Robert AdelsonVerified

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Tom FlynnVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Anurag AgarwalVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Douglas CrawfordVerified

    Venture Capital · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Symbiome, Caribou Biosciences, Calithera Biosciences, Bolt Threads and 18 more

    Verified email available

  • Elizabeth Blake SchwertVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Matt CohenVerified

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Mike RossVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Gregory Madden

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Contact details available

  • Houman Ashrafian

    Venture Capital, Investor · United Kingdom

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Marc Singer

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more

    Contact details available

  • Michael Balmuth

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Brent Faduski

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Carl Culicchia

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Carol GallagherVerified

    Angel/Individual · United States

    E-commerceWomen FoundedAppsArtificial Intelligence (AI)

    Portfolio: Metacrine, Good2Go, Inc., Pionyr Immunotherapeutics, Good2Go and 3 more

    Verified email available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Kirsten Leute

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Contact details available

  • Robert Blazej

    Venture Capital · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Symbiome, Caribou Biosciences, Calithera Biosciences, Bolt Threads and 18 more

    Contact details available

  • Arjun G.Verified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    SeedPre-SeedBiotechnologySocial ImpactMedia and Entertainment

    Portfolio: Pionyr Immunotherapeutics, Centessa Pharmaceuticals, Quanta Therapeutics, Scorpion Therapeutics

    Verified email available

  • John FreundVerified

    Angel/Individual · United States

    Health CareBiotechnologyMedicalTherapeutics

    Portfolio: Pionyr Immunotherapeutics

    Verified email available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Pionyr Immunotherapeutics investors are on Angel Roster?

Angel Roster lists 33 Pionyr Immunotherapeutics investors. 19 of them (58%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (31), Private Equity Firms (9) and University Program Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Pionyr Immunotherapeutics investors invest in?

Among those that list a stage, the most common are Seed (12), Series A (5) and Series B (1).

Where are Pionyr Immunotherapeutics investors based?

Most are based in the United States (31), Canada (1) and the United Kingdom (1).

Which companies have Pionyr Immunotherapeutics investors backed?

The most-backed portfolio companies among them are Antiva Biosciences (17), Aerovate Therapeutics (17), Atsena Therapeutics (17), Aerocare Holdings (11) and EBR Systems (11).

How do I contact Pionyr Immunotherapeutics investors?

Create a free Angel Roster account to search and filter all 33, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.